DNTH vs REG · rev $6.2M vs P/E 34, $12.93B cap
Dianthus Therapeutics Inc. (DNTH) versus Regency Centers Corporation (REG) — a side-by-side from cached financials, not a winner call.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Regency Centers Corporation (REG) is a reit - retail company listed on US.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
REG does not have a complete income-statement cache yet.
DNTH currently screens at market cap $4.40B. REG currently screens at market cap $12.93B and trailing P/E 33.5.
Not investment advice. Open the DNTH and REG stock pages for the full models.
Not investment advice.